Market News AIOpen the app

Novartis shared its goal of 5% annual sales growth and updated its drug plans at Investor Day.

ResultsRead the original at finanzen.ch
Good for NVS

Novartis set sales and profit goals, raised peak-sales forecasts for 3 medicines, and described more than 30 possible medicines that could bring in substantial sales. These plans may help cover upcoming patent losses, but they are not results yet.

NVS · Novartis

AI read · Good for NVS

The AI's read

The larger list of possible medicines gives Novartis more chances to replace sales from older drugs as their patents expire. But the goals and future study results are plans, not proof that sales will grow.

Get alerts for NVS

Follow Novartis (NVS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NVS
Free on the App Store and Google Play, or on the web.